Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia Nelson

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|November 17, 2017
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 yearsFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Drugs - Real World Outcomes|May 29, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with NatalizumabKaren Blitz-Shabbir, Aimee M Banks, Hina Garg, et al.
Multiple Sclerosis and Related Disorders|April 7, 2023
Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study resultsJeffrey Wilken, Anthony Traboulsee, Flavia Nelson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2013
Magnetic resonance imaging outcomes from a phase III trial of teriflunomideJerry S Wolinsky, Ponnada A Narayana, Flavia Nelson, et al.
Annals of Neurology|February 19, 2013
Chronic cerebrospinal venous insufficiency: case-control neurosonography resultsAndrew D Barreto, Staley A Brod, Thanh-Tung Bui, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 22, 2016
Patient-specific 3D FLAIR for enhanced visualization of brain white matter lesions in multiple sclerosisRefaat E Gabr, Amol S Pednekar, Koushik A Govindarajan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 6, 2013
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessmentStaley A Brod, Larry A Kramer, Alan M Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2026
Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosisFarren Bs Briggs, Jevin Litwiler, Federico Montini, et al.
JAMA|January 16, 2019
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical TrialRichard K Burt, Roumen Balabanov, Joachim Burman, et al.
Nature Reviews. Neurology|November 12, 2016
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis CooperativePascal Sati, Jiwon Oh, R Todd Constable, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|November 17, 2017
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 yearsFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Drugs - Real World Outcomes|May 29, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with NatalizumabKaren Blitz-Shabbir, Aimee M Banks, Hina Garg, et al.
Multiple Sclerosis and Related Disorders|April 7, 2023
Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study resultsJeffrey Wilken, Anthony Traboulsee, Flavia Nelson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2013
Magnetic resonance imaging outcomes from a phase III trial of teriflunomideJerry S Wolinsky, Ponnada A Narayana, Flavia Nelson, et al.
Annals of Neurology|February 19, 2013
Chronic cerebrospinal venous insufficiency: case-control neurosonography resultsAndrew D Barreto, Staley A Brod, Thanh-Tung Bui, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 22, 2016
Patient-specific 3D FLAIR for enhanced visualization of brain white matter lesions in multiple sclerosisRefaat E Gabr, Amol S Pednekar, Koushik A Govindarajan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 6, 2013
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessmentStaley A Brod, Larry A Kramer, Alan M Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2026
Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosisFarren Bs Briggs, Jevin Litwiler, Federico Montini, et al.
JAMA|January 16, 2019
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical TrialRichard K Burt, Roumen Balabanov, Joachim Burman, et al.
Nature Reviews. Neurology|November 12, 2016
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis CooperativePascal Sati, Jiwon Oh, R Todd Constable, et al.
Pageof 4